Cardiology Letters 2021, 30(3):148-158
Screening for Arterial Hypertension in Primary Healthcare Facilities in Slovakia - the "Charter 70/2023" Initiative
- 1 Klinika kardiológie a angiológie NÚSCH, a. s. a Lekárská fakulta Slovenskej zdravotníckej univerzity v Bratislave
- 2 Katedry štatistiky, Fakulta hospodárskej informatiky Ekonomickej univerzita v Bratislave
- 3 Benmedika s. r. o., všeobecná ambulancia pre dospelých, Veľký Biel, Slovenská republika
Arterial hypertension (AH) is the most prevalent modifiable risk factor for cardiovascular morbidity and mortality and in about half of the cases it is the determining factor for stroke and coronary heart disease. In addition, significant burdens of atrial fibrillation and heart failure are attributable to AH. At population level, appropriate management of AH is crucial for cardiovascular health. The "Charter 70/2023" is an initiative to improve BP control so that at least 70% of hypertensive patients in Slovakia achieve target BP values by the year 2023. Study aim: To assess the prevalence of AH in Slovak adult population and to evaluate the level of achieved blood pressure (BP) control in hypertensive subjects by screening BP using guideline recommended method for BP measurement. Population and methods: Screening of BP in adult population during visits to 36 general physicians located in all regions of Slovakia. All persons ≥18 years of age, who visited during 1-2 days offices of participating general physicians for any purpose except fever and willing to undergo a short survey and a BP measurement were included. The guideline recommended method for BP measurements consists of 3 consecutive measurements within 5 minutes time after resting in sitting position for 5 minutes. The measured BP value corresponded to the calculated mean value from the last 2 measurements.
Results: The screened population included 1260 persons (797 women, 63%) with a mean age of 49.6 ± 18.9 years, 75% were younger than 65 years. AH was treated in 40% of the population, overweight / obesity was present in 52% of women and 71% of men, 27% were smokers or quitted smoking. AH defined as calculated systolic BP ≥140 mm Hg and /or diastolic BP ≥ 90 mm Hg was found in 431 persons, corresponding to a prevalence of 34.2%. AH was found in 231 women (29%) and 200 men (43%). Optimal BP values (≤120/80 mm Hg) were found in 34% of women and in 13% of men. Comparing BP values from measurement #1 with the mean of the measurements # 2 and # 3 a mean reduction of systolic BP of 6.3 ± 8.3 mm Hg (p < 0.01) and of diastolic BP of 2.6 ± 6.3 mm Hg were found. These findings suggest that performing just a single BP measurement may overestimate the prevalence of hypertension - in our cohort this would be the case in 163 persons (13%). Among 509 patients with AH (40.4% of the cohort) acceptable BP values of <140/90 mm Hg were found in 232 patients (45.6%). Detection of hypertension during screening in persons not treated for AH identified 144 patients (11.4%) in whom diagnosis of AH will possibly be confirmed with new measurements after variable time delay.
Conclusion: BP should be measured with the standardised guideline recommended oscillometric method with 3 consecutive measurements with final value calculated as mean of the 2 last measurements. First measurement incorrectly increases the value of systolic BP by 6.3 ± 8.3 mmHg (p < 0.01) and that of diastolic BP by 2.6 ± 6.3 mmHg. This would falsely increase the relative proportion of hypertensives in the studied population by 13%. With the correct technique of BP measurement 34.2% prevalence of AH was calculated for our population. Insufficient, above target BP values were found in 54.4% of treated hypertensives. Thus, an unmet need for improving BP control in the general population in Slovakia is evident and should be addressed.
Keywords: blood pressure; arterial hypertension; primary healthcare
Published: March 1, 2021 Show citation
References
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1.
Go to original source... - Williams B, Mancia G, Spiering, et al.; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019; 40(5):475.
Go to original source... - Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371(9623):1513-8. doi: 10.1016/S01406736(08)60655-8..
Go to original source... - OECD Health Statistics 2013, http://dx.doi.org/10.1787/healthdata-en
- Neal B, MacMahon S, Chapman N, et al.; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356(9246):1955-64. doi: 10.1016/s0140-6736(00)03307-9.
Go to original source... - Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362(9395):152735. doi: 10.1016/s0140-6736(03)14739-3.
Go to original source... - Ceral J, Habrdova V, Vorisek V, et al. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011;34(1):87-90. doi: 10.1038/hr.2010.183.
Go to original source... - Agentúra Allio. Odporúčania ESC/ESH 2018 - implementácia. Multi-client study 2019. Nepublikované údaje, Bratislava 2020.
- Tocci G, Borghi C, Volpe M. Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control. High Blood Press Cardiovasc Prev. 2014; 21(2):107-17. doi: 10.1007/s40292-013-0028-x.
Go to original source... - Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005; 5(1):18. doi
Go to original source... - 1186/1471-2261-5-18.
- Myers MG, Godwin M. Automated office blood pressure. Can J Cardiol. 2012; 28(3):341-6. doi: 10.1016/j.cjca.2011.09.004.
Go to original source... - Han X, McCombs J, Chu M, Dougherty JS, Fox DS. Impact of early initiation of antihypertensive medications for patients with hypertension or elevated blood pressure. J Hypertens. 2019; 37(6):1276-1284. doi: 10.1097/HJH.0000000000002014.
Go to original source... - Kotseva K, De Backer G, De Bacquer D, et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol. 2020: 2047487320908698. doi: 10.1177/2047487320908698.
Go to original source... - Paulsen MS, Sondergaard J, Reuther L, et al. Treatment of 5413 hypertensive patients: a cross-sectional study. Fam Pract. 2011; 28(6):599-607. doi: 10.1093/fampra/cmr027.
Go to original source... - Slovenská kardiologická spoločnosť: Charta 70/2023. http://www.sks.sk/news/charta-702023
- Zdravotnícka ročenka Slovenskej republiky 2019, Národné centrum zdravotníckych informácií. http://www.nczisk.sk/Documents/rocenky/2019/Zdravotnicka_rocenka_Slovenskej_republiky_2019.pdf
- Slovenská kardiologická spoločnosť. Charta 70/2023. http://www.sks.sk/news/charta-702023

